Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Sio Gene Therapies Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −8 vs. Q4 2021
- Shares held
- 18.1M
- −3.23M (−15.1%) vs. Q4 2021
- Total value
- $12.1M
- −$15.4M (−56.0%) vs. Q4 2021
- New holders
- 3
- 7 more added
- Sold out
- 11
- 17 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SIOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $26.0K |
| Q1 2023 | 4 | $1.13M |
| Q4 2022 | 37 | $8.09M |
| Q3 2022 | 38 | $5.91M |
| Q2 2022 | 41 | $7.44M |
| Q1 2022 | 40 | $12.1M |
| Q4 2021 | 48 | $27.6M |
| Q3 2021 | 55 | $39.9M |
| Q2 2021 | 53 | $56.1M |
| Q1 2021 | 55 | $53.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Sio Gene Therapies Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fifth Third Bancorp | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 337 | $0 | 0.00% | +2+0.6% | Added |
| The PNC Financial Services Group, Inc. | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 179 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 312 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 700 | $0 | 0.00% | +700 | New |
| Wolff Wiese Magana LLC | 400 | $0 | 0.00% | +400 | New |
| Captrust Financial Advisors | 1,018 | $1.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,964 | $2.00K | 0.00% | −1,800−37.8% | Reduced |
| Bank of America Corp | 8,466 | $6.00K | 0.00% | −12,911−60.4% | Reduced |
| Tower Research Capital LLC (TRC) | 8,262 | $6.00K | 0.00% | −3,811−31.6% | Reduced |
| Two Sigma Securities, LLC | 10,918 | $7.00K | 0.00% | −23,557−68.3% | Reduced |
| Bank of Montreal | 10,000 | $7.00K | 0.00% | +10,000 | New |
| Primecap Management Co | 18,300 | $12.0K | 0.00% | −1,800−9.0% | Reduced |
| Morgan Stanley | 17,254 | $12.0K | 0.00% | −842−4.7% | Reduced |
| Verition Fund Management LLC | 20,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 26,912 | $18.0K | 0.00% | +15,997+146.6% | Added |
| New York Life Investments Alternatives | 49,528 | $33.0K | 0.02% | −10,717−17.8% | Reduced |
| Two Sigma Advisers, LP | 55,838 | $37.0K | 0.00% | −15,400−21.6% | Reduced |
| Susquehanna International Group, LLP | 61,733 | $41.0K | 0.00% | −48,092−43.8% | Reduced |
| Macquarie Group Ltd | 64,170 | $43.0K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 82,122 | $55.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 87,153 | $58.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 95,446 | $64.0K | 0.00% | +64,839+211.8% | Added |
| ACT Capital Management, LLC | 146,500 | $98.0K | 0.10% | −38,500−20.8% | Reduced |
| State Street Corp | 167,121 | $112.0K | 0.00% | +9,921+6.3% | Added |
| Dimensional Fund Advisors LP | 190,670 | $128.0K | 0.00% | −362,064−65.5% | Reduced |
| Citadel Advisors LLC | 208,065 | $139.0K | 0.00% | +73,055+54.1% | Added |
| Bridgeway Capital Management, LLC | 244,900 | $164.0K | 0.00% | −100,000−29.0% | Reduced |
| Clearline Capital LP | 392,691 | $263.0K | 0.04% | +174,185+79.7% | Added |
| Geode Capital Management, LLC | 431,208 | $288.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 524,123 | $352.0K | 0.00% | −6,552−1.2% | Reduced |
| Renaissance Technologies LLC | 567,153 | $380.0K | 0.00% | −86,547−13.2% | Reduced |
| Prosight Management, LP | 670,300 | $449.0K | 0.32% | −131,880−16.4% | Reduced |
| Cladis Investment Advisory, LLC | 1,246,000 | $834.8K | 0.68% | +42,000+3.5% | Added |
| Hudson Bay Capital Management LP | 1,682,000 | $1.13M | 0.02% | −118,000−6.6% | Reduced |
| Vanguard Group Inc | 2,098,581 | $1.41M | 0.00% | −50,571−2.4% | Reduced |
| Rubric Capital Management LP | 3,000,000 | $2.01M | 0.09% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 5,914,000 | $3.96M | 0.12% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 0 | $0 | 0.00% | −1,806,542−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −382,004−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −166,806−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −147,254−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,259−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −20,023−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −20,613−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −18,066−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −17,355−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Edge Wealth Management LLC | 0 | $0 | 0.00% | −320−100.0% | Sold out |